Hyperphosphatemia Treatment Market

 Hyperphosphatemia is a serum phosphate concentration?>?4.5 mg/dL (>?1.46 mmol/L). Causes include chronic kidney disease, hypoparathyroidism, and metabolic or respiratory acidosis. Clinical features may be due to accompanying hypocalcemia and include tetany. Diagnosis is by serum phosphate measurement. Treatment includes restriction of phosphate intake and administration of phosphate-binding antacids, such as calcium carbonate.

This report contains market size and forecasts of Hyperphosphatemia Treatment in Global, including the following market information:

  • Global Hyperphosphatemia Treatment Market Revenue, 2018-2023, 2023-2030, ($ millions)
Report Sample includes:
- Table of Contents
- List of Tables & Figures
- Charts
- Research Methodology

Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-hyperphosphatemia-treatment-forecast-2023-2030-217

The global Hyperphosphatemia Treatment market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.

The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.

Sevelamer Segment to Reach $ Million by 2030, with a % CAGR in next six years.

The global key manufacturers of Hyperphosphatemia Treatment include Sanofi, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Akebia Therapeutics,Inc, Vifor Pharma Management Ltd., Lupin Limited, Ardelyx,Inc., Unicycive Therapeutics Inc. and Keryx Biopharmaceuticals and etc. In 2022, the global top five players have a share approximately % in terms of revenue.

We surveyed the Hyperphosphatemia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hyperphosphatemia Treatment Market, by Type, 2018-2023, 2023-2030 ($ millions)

Global Hyperphosphatemia Treatment Market Segment Percentages, by Type, 2022 (%)

  • Sevelamer
  • Calcium-based Phosphate Binders
  • Iron-based Phosphate Binders
  • Lanthanum Carbonate
  • Non-phosphate Binders
  • Others

Global Hyperphosphatemia Treatment Market, by Application, 2018-2023, 2023-2030 ($ millions)

Global Hyperphosphatemia Treatment Market Segment Percentages, by Application, 2022 (%)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Stores
  • Others

Global Hyperphosphatemia Treatment Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)

Global Hyperphosphatemia Treatment Market Segment Percentages, By Region and Country, 2022 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

  • Key companies Hyperphosphatemia Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
  • Key companies Hyperphosphatemia Treatment revenues share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • Sanofi
  • Takeda Pharmaceutical Company Limited
  • Astellas Pharma Inc.
  • Akebia Therapeutics,Inc
  • Vifor Pharma Management Ltd.
  • Lupin Limited
  • Ardelyx,Inc.
  • Unicycive Therapeutics Inc.
  • Keryx Biopharmaceuticals
  • Zeria Pharmaceutical
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports

Comments

Popular posts from this blog

Fossil Fuel Hydrogen Production Market 2023

Screw Expander Market, Global Outlook and Forecast 2023-2029

Composting Toilet Market